Jean von Agris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jean von Agris has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Garrett Wallace Brown
School of Politics and International Studies (POLIS), University of Leeds, Leeds, UK
6 shared publications - David Bell
Independent Consultant, Lake Jackson, TX 77566, USA
5 shared publications - Blagovesta Tacheva
University of Leeds
3 shared publications - Elisabeth Paul
School of Public Health, Université Libre de Bruxelles, Bruxelles, Belgium
2 shared publications - Gemma Bridge
University of Leeds
2 shared publications Blagovesta Tacheva
School of Politics and International Studies, University of Leeds, Leeds, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Global Policy
Do Global Burden of Disease COVID‐19 Estimates Inflate Covid Mortality Over Mortality From the Response?
Pandemic preparedness and response have become central to global health and are driving deep changes in management and resource allocation. Understanding COVID‐19's burden relative to other diseases and the impact of response interventions is therefore crucial for effective policy. The Global Burden of Disease (GBD) project has estimated 12.7 million COVID‐19 deaths within an excess mortality of 15.9 million for 2020–21, figures significantly higher than other sources. Given GBD's traditional importance for policymaking, we assessed the approach used and its likelihood of producing valid estimates. In doing so, analysis revealed that the GBD model assumes questionable higher‐than‐reported COVID‐19 mortality in populations with low vaccine uptake or low compliance with non‐pharmaceutical interventions (NPIs). GBD cites limited evidence for NPI effectiveness, counts response harms as excess mortality, and applies vaccine efficacies higher than many published reports, risking bias by inflating COVID‐19 mortality. To inform current policy changes in global policy, including proportionate and effective pandemic policy, it is critical to have a reliable understanding of the outcomes of the COVID‐19 event. The GBD's approach raises questions about the reliability of its mortality estimates and the public health response, suggesting a need for a better evidence base to inform future global health reform.
- 16 November 2026
- Published by Wiley in Global Policy
Open AccessDo Global Burden of Disease COVID‐19 Estimates Inflate Covid Mortality Over Mortality From the Response?
Pandemic preparedness and response have become central to global health and are driving deep changes in management and resource allocation. Understanding COVID‐19's burden relative to other diseases and the impact of response interventions is therefore crucial for effective policy. The Global Burden of Disease (GBD) project has estimated 12.7 million COVID‐19 deaths within an excess mortality of 15.9 million for 2020–21, figures significantly higher than other sources. Given GBD's traditional importance for policymaking, we assessed the approach used and its likelihood of producing valid estimates. In doing so, analysis revealed that the GBD model assumes questionable higher‐than‐reported COVID‐19 mortality in populations with low vaccine uptake or low compliance with non‐pharmaceutical interventions (NPIs). GBD cites limited evidence for NPI effectiveness, counts response harms as excess mortality, and applies vaccine efficacies higher than many published reports, risking bias by inflating COVID‐19 mortality. To inform current policy changes in global policy, including proportionate and effective pandemic policy, it is critical to have a reliable understanding of the outcomes of the COVID‐19 event. The GBD's approach raises questions about the reliability of its mortality estimates and the public health response, suggesting a need for a better evidence base to inform future global health reform.
- Open Access
- 28 October 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1664330
WHO’s pandemic response recommendations after COVID-19: lessons learned or learnings lost?
Objectives: This article examines how the World Health Organization’s (WHO) recommendations and guidelines on public health and social measures (PHSM) have changed since COVID-19. Doing so allows insights on what lessons WHO has learned from the COVID-19 response. Methods: The article analyses six recent WHO publications detailing recommendations on PHSM and compares them against three pre-COVID-19 WHO documents. The analysis also assesses the evidence-base used for these recommendations to better understand WHO’s substantive basis and rationale for the PHSM changes. Results: The analysis reveals substantial changes in WHO recommendations, often without systematic evidence assessment. Several population-wide interventions including quarantine, travel measures, and universal masking have become normalized in post-COVID documents, despite being previously discouraged. When evidence is cited, it often pertains to narrowly defined short-term outcomes, with limited consideration of broader societal impacts. Adverse effects of PHSM are recognized, but mitigation takes priority over avoiding harms. Conclusion: Systematic evaluation of the evidence on PHSM during the COVID-19 pandemic, including their effectiveness and collateral effects, is imperative before revising changes in recommendations for future pandemics.
- 28 October 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1664330
Open AccessWHO’s pandemic response recommendations after COVID-19: lessons learned or learnings lost?
Objectives: This article examines how the World Health Organization’s (WHO) recommendations and guidelines on public health and social measures (PHSM) have changed since COVID-19. Doing so allows insights on what lessons WHO has learned from the COVID-19 response. Methods: The article analyses six recent WHO publications detailing recommendations on PHSM and compares them against three pre-COVID-19 WHO documents. The analysis also assesses the evidence-base used for these recommendations to better understand WHO’s substantive basis and rationale for the PHSM changes. Results: The analysis reveals substantial changes in WHO recommendations, often without systematic evidence assessment. Several population-wide interventions including quarantine, travel measures, and universal masking have become normalized in post-COVID documents, despite being previously discouraged. When evidence is cited, it often pertains to narrowly defined short-term outcomes, with limited consideration of broader societal impacts. Adverse effects of PHSM are recognized, but mitigation takes priority over avoiding harms. Conclusion: Systematic evaluation of the evidence on PHSM during the COVID-19 pandemic, including their effectiveness and collateral effects, is imperative before revising changes in recommendations for future pandemics.
- Open Access
- 15 September 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (9) , e018252
It is time to increase Africa’s governmental representation on the governing board of the global fund to fight AIDS, tuberculosis and malaria
The response to COVID-19 exposed a lack of African capacity to influence global health decision-making and policy. A more general recognition of limited African voice has also been reflected in reform debates within Global Health Initiatives (GHIs) as well as in more traditional sites of geopolitical power, such as the United Nations Security Council. Yet, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) was once heralded as the innovative partnerships for health, its governance structure has not kept pace with emerging global norms that advocate for greater African representation, national ownership, sustainable development and greater aid effectiveness.
- 15 September 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (9) , e018252
Open AccessIt is time to increase Africa’s governmental representation on the governing board of the global fund to fight AIDS, tuberculosis and malaria
The response to COVID-19 exposed a lack of African capacity to influence global health decision-making and policy. A more general recognition of limited African voice has also been reflected in reform debates within Global Health Initiatives (GHIs) as well as in more traditional sites of geopolitical power, such as the United Nations Security Council. Yet, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) was once heralded as the innovative partnerships for health, its governance structure has not kept pace with emerging global norms that advocate for greater African representation, national ownership, sustainable development and greater aid effectiveness.
- Open Access
- 24 April 2025
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 15 (1) , 1-13
Natural Spillover Risk and Disease Outbreaks: Is Over-Simplification Putting Public Health at Risk?
The pandemic prevention, preparedness and response (PPPR) agenda is currently dominating international public health. International agencies including the World Health Organization and World Bank are proposing an unprecedented level of funding that will inevitably have broad consequences across health and society. Arguments supporting pandemic policy are heavily based on the premise that pandemic risk is rapidly increasing, driven in particular by passage of pathogens from animal reservoirs to establish transmission in the human population; ‘zoonotic spillover’. Proposed drivers for increasing spillover are mostly based on environmental change attributed to anthropogenic origin, including deforestation, agricultural expansion and intensification, and changes in climate. Much of the literature, including reports published by international agencies and peer-reviewed papers, offers support for fundamental changes in public health policy premised on definitive statements that spillover is indeed increasing, that underlying anthropogenic drivers are the main reason for this, and that these are remediable. However, many of these assumptions are poorly supported by cited literature, over-simplifying a highly complex set of ecological interactions. This picture is further complicated by rapidly and unevenly evolving capacity for pathogen detection and notification. Public health policy based on incorrect assumptions and overly simplified analyses is likely to lead to poorly designed interventions and poor outcomes. If we are to deal effectively with outbreak risk within the broad context of competing public health priorities, there is an urgent need to re-evaluate current assumptions on drivers of outbreaks based on available evidence and address continuing major gaps in knowledge.
- 24 April 2025
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 15 (1) , 1-13
Open AccessNatural Spillover Risk and Disease Outbreaks: Is Over-Simplification Putting Public Health at Risk?
The pandemic prevention, preparedness and response (PPPR) agenda is currently dominating international public health. International agencies including the World Health Organization and World Bank are proposing an unprecedented level of funding that will inevitably have broad consequences across health and society. Arguments supporting pandemic policy are heavily based on the premise that pandemic risk is rapidly increasing, driven in particular by passage of pathogens from animal reservoirs to establish transmission in the human population; ‘zoonotic spillover’. Proposed drivers for increasing spillover are mostly based on environmental change attributed to anthropogenic origin, including deforestation, agricultural expansion and intensification, and changes in climate. Much of the literature, including reports published by international agencies and peer-reviewed papers, offers support for fundamental changes in public health policy premised on definitive statements that spillover is indeed increasing, that underlying anthropogenic drivers are the main reason for this, and that these are remediable. However, many of these assumptions are poorly supported by cited literature, over-simplifying a highly complex set of ecological interactions. This picture is further complicated by rapidly and unevenly evolving capacity for pathogen detection and notification. Public health policy based on incorrect assumptions and overly simplified analyses is likely to lead to poorly designed interventions and poor outcomes. If we are to deal effectively with outbreak risk within the broad context of competing public health priorities, there is an urgent need to re-evaluate current assumptions on drivers of outbreaks based on available evidence and address continuing major gaps in knowledge.
- Open Access
- 12 April 2025
- Published by Wiley in Global Policy
- Vol. 16 (2) , 410-418
Should Eminence Outweigh Evidence? The Global Preparedness Monitoring Board's Report on Pandemic Preparedness
The Global Pandemic Monitoring Board (GPMB) is a group of eminent individuals publishing reports calling for increased emphasis on pandemic prevention, preparedness, and response (PPPR). They advocate for the World Health Organization's (WHO) PPPR preferred approach and its attendant financial requests. Though claiming independence, GPMB is co‐convened by WHO and the World Bank. The GPMB report of January 2025 displays a selective approach in which drivers of increased outbreak risk are emphasized while drivers mitigating risk are ignored. The impression, reinforced by the GPMB's conclusions, is of an inexorable increase in pandemic risk. In ignoring the balance between various epidemiological and behavioral drivers, the predictions promoted through the report are divorced from real‐world expectation. Claims that “Individualism” is a major driver of risk, and misinformation an important promoter of harm, are backed by a weak evidence base. This raises important concerns regarding human rights and the arbitration of correct and incorrect information by specific institutions. The use of eminent committees such as GPMB to advocate to governments and media risks undermining the role of evidence in public health policymaking. WHO should consider requiring a structured approach emphasizing costs and benefits, leaving advocacy to Member States in their own context.
- 12 April 2025
- Published by Wiley in Global Policy
- Vol. 16 (2) , 410-418
Open AccessShould Eminence Outweigh Evidence? The Global Preparedness Monitoring Board's Report on Pandemic Preparedness
The Global Pandemic Monitoring Board (GPMB) is a group of eminent individuals publishing reports calling for increased emphasis on pandemic prevention, preparedness, and response (PPPR). They advocate for the World Health Organization's (WHO) PPPR preferred approach and its attendant financial requests. Though claiming independence, GPMB is co‐convened by WHO and the World Bank. The GPMB report of January 2025 displays a selective approach in which drivers of increased outbreak risk are emphasized while drivers mitigating risk are ignored. The impression, reinforced by the GPMB's conclusions, is of an inexorable increase in pandemic risk. In ignoring the balance between various epidemiological and behavioral drivers, the predictions promoted through the report are divorced from real‐world expectation. Claims that “Individualism” is a major driver of risk, and misinformation an important promoter of harm, are backed by a weak evidence base. This raises important concerns regarding human rights and the arbitration of correct and incorrect information by specific institutions. The use of eminent committees such as GPMB to advocate to governments and media risks undermining the role of evidence in public health policymaking. WHO should consider requiring a structured approach emphasizing costs and benefits, leaving advocacy to Member States in their own context.
- Open Access
- 12 March 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (6) , 102749
Perspective: An overemphasis on vaccines for Mpox skewes important lessons from COVID-19 and the need for public health approaches
- 12 March 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (6) , 102749
Open AccessPerspective: An overemphasis on vaccines for Mpox skewes important lessons from COVID-19 and the need for public health approaches
- Open Access
- 22 May 2024
- Published by Taylor & Francis in Critical Public Health
- Vol. 34 (1) , 1-10
Royal Society report: what would a comprehensive evaluation suggest about non-pharmaceutical interventions during COVID-19?
- 22 May 2024
- Published by Taylor & Francis in Critical Public Health
- Vol. 34 (1) , 1-10
Open AccessRoyal Society report: what would a comprehensive evaluation suggest about non-pharmaceutical interventions during COVID-19?